Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

108 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
DiNicolantonio JJ, Hackam DG. DiNicolantonio JJ, et al. Among authors: hackam dg. Expert Rev Cardiovasc Ther. 2012 Jan;10(1):13-25. doi: 10.1586/erc.11.166. Expert Rev Cardiovasc Ther. 2012. PMID: 22149523 Review.
Perioperative beta-blocker therapy in vascular surgery: clinical update.
Hackam DG. Hackam DG. J Vasc Surg. 2006 Mar;43(3):632-4. doi: 10.1016/j.jvs.2005.12.014. J Vasc Surg. 2006. PMID: 16520187 Review.
β-Blocker dialyzability and mortality in older patients receiving hemodialysis.
Weir MA, Dixon SN, Fleet JL, Roberts MA, Hackam DG, Oliver MJ, Suri RS, Quinn RR, Ozair S, Beyea MM, Kitchlu A, Garg AX. Weir MA, et al. Among authors: hackam dg. J Am Soc Nephrol. 2015 Apr;26(4):987-96. doi: 10.1681/ASN.2014040324. Epub 2014 Oct 30. J Am Soc Nephrol. 2015. PMID: 25359874 Free PMC article.
Antithrombotic treatment for peripheral arterial disease.
Hackam DG, Eikelboom JW. Hackam DG, et al. Heart. 2007 Mar;93(3):303-8. doi: 10.1136/hrt.2006.102350. Epub 2006 Oct 11. Heart. 2007. PMID: 17035509 Free PMC article. Review.
Carotid plaque area: a tool for targeting and evaluating vascular preventive therapy.
Spence JD, Eliasziw M, DiCicco M, Hackam DG, Galil R, Lohmann T. Spence JD, et al. Among authors: hackam dg. Stroke. 2002 Dec;33(12):2916-22. doi: 10.1161/01.str.0000042207.16156.b9. Stroke. 2002. PMID: 12468791 Clinical Trial.
Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study.
Hackam DG, Spence JD. Hackam DG, et al. Stroke. 2007 Jun;38(6):1881-5. doi: 10.1161/STROKEAHA.106.475525. Epub 2007 Apr 12. Stroke. 2007. PMID: 17431209
Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.
Hackam DG, Anand SS. Hackam DG, et al. JAMA. 2003 Aug 20;290(7):932-40. doi: 10.1001/jama.290.7.932. JAMA. 2003. PMID: 12928471 Review.
C-reactive protein for the prediction of cardiovascular risk: ready for prime-time?
Hackam DG, Shumak SL. Hackam DG, et al. CMAJ. 2004 May 11;170(10):1563-5. doi: 10.1503/cmaj.1031968. CMAJ. 2004. PMID: 15136550 Free PMC article. No abstract available.
Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription.
Lam NN, Jain AK, Hackam DG, Cuerden MS, Suri RS, Huo CY, Li P, Clark WF, Garg AX. Lam NN, et al. Among authors: hackam dg. Kidney Int. 2009 Dec;76(11):1172-9. doi: 10.1038/ki.2009.323. Epub 2009 Sep 23. Kidney Int. 2009. PMID: 19776719
Systematic review and meta-analysis: when one study is just not enough.
Garg AX, Hackam D, Tonelli M. Garg AX, et al. Among authors: hackam d. Clin J Am Soc Nephrol. 2008 Jan;3(1):253-60. doi: 10.2215/CJN.01430307. Clin J Am Soc Nephrol. 2008. PMID: 18178786 Review. No abstract available.
108 results
Jump to page
Feedback